Long-Term Visual Outcomes for a Treat-and-Extend Antivascular Endothelial Growth Factor Regimen in Eyes with Neovascular Age-Related Macular Degeneration: Up to Seven-Year Follow-Up

Figure 3

Distribution of changes in BCVA from baseline (equivalent ETDRS letter score). Note: ETDRS equivalent was calculated from LogMAR values.